Results 21 to 30 of about 266,144 (301)

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]

open access: yes, 2011
Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M.   +15 more
core   +1 more source

Electrical conductivity measurement in Thiel-embalmed tissue model : relevance to radiofrequency ablation [PDF]

open access: yes, 2014
PA gratefully acknowledges SUPA for funding his Advanced Research Fellowship.Thiel-embalmed human cadaveric specimens are used widely for biomedical scientific investigation.
Andre, P.   +11 more
core   +1 more source

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival

open access: yes, 2023
Background: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases.
Okan Akhan   +11 more
core   +1 more source

Radiofrequency ablation of lymphoma

open access: yesBlood, 2006
Percutaneous minimally invasive radiofrequency (RF) ablation has not been described for lymphoma. This image-guided modality is presented in 3 different settings for the treatment of refractory lymphoma. The first patient received RF ablation for the curative treatment of a solitary residual hepatic mass following rituximab-based chemotherapy for a ...
Deepak, Sudheendra   +4 more
openaire   +3 more sources

Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation [PDF]

open access: yes, 2012
Purpose: To evaluate the efficiency of a multimodality approach consisting of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) as bridging therapy for patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver
Rentsch, M.   +33 more
core   +1 more source

Perivascular radiofrequency renal denervation lowers blood pressure and ameliorates cardiorenal fibrosis in spontaneously hypertensive rats. [PDF]

open access: yesPLoS ONE, 2017
BACKGROUND:Catheter-based renal denervation (RDN) is a promising approach to treat hypertension, but innervation patterns limit the response to endovascular RDN and the post-procedural renal artery narrowing or stenosis questions the endovascular ...
Shujie Wei   +9 more
doaj   +1 more source

Advances in Imaging for Atrial Fibrillation Ablation [PDF]

open access: yes, 2011
Over the last fifteen years, our understanding of the pathophysiology of atrial fibrillation (AF) has paved the way for ablation to be utilized as an effective treatment option.
Andrew D'Silva   +3 more
core   +1 more source

Radiofrequency Ablation [PDF]

open access: yesAcademic Radiology, 2009
Inflammatory reaction surrounding the ablated area is a major confounding factor in the early detection of viable tumor after radiofrequency (RF) ablation. A difference in the responsiveness of normal and tumor blood vessels to vasoactive agents may be used to distinguish these regions in post-ablation follow-up.
Hanping, Wu   +5 more
openaire   +2 more sources

Length of Barrett’s segment predicts failure of eradication in radiofrequency ablation for Barrett’s esophagus: a retrospective cohort study

open access: yesBMC Gastroenterology, 2018
Background We aim to investigate factors that may contribute to failure of eradication of dysplastic Barrett’s Esophagus among patients undergoing radiofrequency ablation treatment.
Tyler Luckett   +5 more
doaj   +1 more source

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation [PDF]

open access: yes, 2014
Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare.
Breen, D.   +35 more
core   +1 more source

Home - About - Disclaimer - Privacy